Baseline glutathione peroxidase activity affects prognosis after acute coronary syndromes

Texas Heart Institute Journal

Volumn 35, Issue 3, 2008, Pages 262-267

  García Pinilla, José Manuel ^a   Gálvez, Julio ^b   Cabrera Bueno, Fernando ^a   Jiménez Navarro, Manuel ^a   Gómez Doblas, Juan José ^a   Galisteo, Milagros ^b   Camuesco, Desiré ^b   Galván, Carlos De Teresa ^c   Espinosa Caliani, Salvador ^a   Zarzuelo, Antonio ^b   De Teresa Galván, Eduardo ^a,d  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c Hospital San Juan de Dios   (Spain)

^d UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Acute coronary syndromes; Arteriosclerosis etiology; Biological markers blood; Glutathione peroxidase; Oxidation reduction; Oxidative stress; Prognosis

Indexed keywords

GLUTATHIONE PEROXIDASE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROGNOSIS;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE;

EID: 56049092367     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Glass CK, Witztum JL. Atherosclerosis. the road ahead [sic]. Cell 2001;104(4):503-16.
2. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342(3):154-60.
3. Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 2002;105(17):2107-11.
4. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret L, et al.; AtheroGene Investigators. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 2003;349(17):1605-13.
5. Forgione MA, Cap A, Liao R, Moldovan NI, Eberhardt RT, Lim CC, et al. Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure. Circulation 2002;106(9):1154-8.
6. Shiomi T, Tsutsui H, Matsusaka H, Murakami K, Hayashidani S, Ikeuchi M, et al. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 2004;109(4):544-9.
7. Schnabel R, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Torzewski M, Lubos E, et al. Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study. J Am Coll Cardiol 2005;45(10):1631-7.
8. Weinbrenner T, Cladellas M, Isabel Covas M, Fito M, Tomas M, Senti M, et al. High oxidative stress in patients with stable coronary heart disease. Atherosclerosis 2003;168(1):99-106.
9. Pandey NR, Kaur G, Chandra M, Sanwal GG, Misra MK. Enzymatic oxidant and antioxidants of human blood platelets in unstable angina and myocardial infarction. Int J Cardiol 2000;76(1):33-8.
10. Zachara BA, Ukleja-Adamowicz M, Nartowicz E, Lecka J. Increased plasma glutathione peroxidase activity in patients with acute myocardial infarction. Med Sci Monit 2001;7(3):415-20.
11. Bor MV, Cevik C, Uslu I, Guneral F, Duzgun E. Selenium levels and glutathione peroxidase activities in patients with acute myocardial infarction. Acta Cardiol 1999;54(5):271-6.
12. Rajasekhar D, Srinivasa Rao PV, Latheef SA, Saibaba KS, Subramanyam G. Association of serum antioxidants and risk of coronary heart disease in South Indian population. Indian J Med Sci 2004;58(11):465-71.
13. Lopez Bescos L, Aros Borau F, Lidon Corbi RM, Cequier Fillat A, Bueno H, Alonso JJ, et al. 2002 update of the guidelines of the Spanish Society of Cardiology for unstable angina/without ST-segment elevation myocardial infarction [in Spanish]. Rev Esp Cardiol 2002;55(6):631-42.
14. Flohe L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984;105:114-21.
15. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006;333(7578):1091.
16. Stephens JW, Gable DR, Hurel SJ, Miller GJ, Cooper JA, Humphries SE. Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males. Clin Chem 2006;52(3):446-52.
17. Vassalle C, Botto N, Andreassi MG, Berti S, Biagini A. Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coron Artery Dis 2003;14(3):213-8.
18. Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 2004;256(4):308-15.
19. Vassalle C, Boni C, Di Cecco P, Landi P. Elevated hydroperoxide levels as a prognostic predictor of mortality in a cohort of patients with cardiovascular disease. Int J Cardiol 2006;110(3):415-6.
20. Forgione MA, Weiss N, Heydrick S, Cap A, Klings ES, Bierl C, et al. Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am J Physiol Heart Circ Physiol 2002;282(4):H1255-61.
21. Dayal S, Brown KL, Weydert CJ, Oberley LW, Arning E, Bottiglieri T, et al. Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction. Arterioscler Thromb Vasc Biol 2002;22(12):1996-2002.
22. Zhou X, Zhai X, Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation 1996;93(6):1177-84.
23. Elesber AA, Best PJ, Lennon RJ, Mathew V, Rihal CS, Lerman LO, Lerman A. Plasma 8-iso-prostaglandin F2alpha, a marker of oxidative stress, is increased in patients with acute myocardial infarction. Free Radic Res 2006;40(4):385-91.
24. Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes: part III: biomarkers of oxidative stress and angiogenic growth factors. Circulation 2006;113(8):e289-92.
25. Saraiva RM, Minhas KM, Raju SV, Barouch LA, Pitz E, Schuleri KH, et al. Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium. Circulation 2005;112(22):3415-22.
26. Vasilyev N, Williams T, Brennan ML, Unzek S, Zhou X, Heinecke JW, et al. Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction. Circulation 2005;112(18):2812-20.
27. Berg K, Wiseth R, Bjerve K, Brurok H, Gunnes S, Skarra S, et al. Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release. Free Radic Res 2004;38(5):517-25.
28. Violi F, Loffredo L, Musella L, Marcoccia A. Should antioxidant status be considered in interventional trials with antioxidants? Heart 2004;90(6):598-602.